Seeking to ensure fulfilment of Vilniaus baldai AB credit agreement,the company mortgaged 15 % block of Vilniaus baldai AB shares to banks. Alvydas BanysVice-president+370 5 279 06 91
MoreThe company’s preliminary un-audited net profit, prepared according to IAS, for the first half of 2005 is LTL 5961558 (EUR 1726587) Alvydas BanysVice-president+370 5 279 06 91
MoreThe largest Lithuanian pharmaceutical company “Sanitas” took over the control of purchased Slovak pharmaceutical plant “Hoechst-Biotika” today. The purchase price is LTL 43.85 mln. “The settlement with the sellers of “Hoechst-Biotika” went..
MoreOn July 15 2005 after new issue of registered ordinary shares of AB Sanitas and increase of AB Sanitas share capital to 11 000 000 LTL, AB Invalda group has..
MoreAB “Invalda” Material Event Preliminary result for the first quarter of 2005 The company’s preliminary un-audited net profit for the first quarter of 2005 is LTL 1886160. Alvydas BanysVice-president+370 5..
MorePress Release 2005 05 30 The largest Lithuanian pharmaceutical company “Sanitas” is purchasing the Slovak pharmaceutical company “Hoechst-Biotika” for approximately LTL 40 mln. The agreement was signed on Friday. According..
MoreInvalda AB Company event AGM decisions The company’s annual general meeting of shareholders held on April 28, 2005 approved the 2004 report on the activities of the company, the annual..
MoreInvalda ABCompany event The audited consolidated net profit of Invalda AB of 2004 The company’s audited consolidated net profit of 2004 amounts to LTL 19631003. Alvydas BanysVice-President(+370 5) 279 06..
MoreInvalda ABCompany event Annual general meeting of shareholders 1. By the decision of the Board the annual general meeting of shareholders isconvened to be held on April 28, 2005 at..
More